Treating dogs at a community level with systemic insecticide could considerably reduce the transmission of visceral leishmaniasis in Brazil, according to a modelling study led by ISGlobal, an institution supported by “la Caixa” Foundation. The results, published in PLOS Neglected Tropical Diseases, will help define which kind of insecticide is needed and how to apply it to achieve maximum effectiveness.
Zoonotic visceral leishmaniasis is caused by the Leishmania infantum parasite and can be lethal. It is transmitted to humans through the bite of female sand flies that feed on infected mammals, particularly dogs. In Brazil, where disease prevalence is high (more than 3,000 cases per year), the culling of infected dogs has proven inefficient in controlling parasite transmission. Treating community dogs with systemic insecticide (i.e. that enters blood circulation) could represent an alternative, although to date there are no systemic insecticides registered for use against sand flies.
In this study, the researchers developed a mathematical model to estimate the impact of systemic insecticides in dogs on the number of human infections by L. infantum, in an endemic region in Brazil. They considered different combinations of insecticide efficacy, percentage of treated dogs, and duration of insecticide activity. The model revealed that, in order to halve the number of cases, 70% of community dogs should be treated with an insecticide whose initial efficacy is of 80% and does not drop below 65% during six months. The same result can be obtained with other combinations of coverage, efficacy, and duration.
“Our model predicts that, at the community level, the use of systemic insecticides targeting the parasite’s canine reservoir could considerably reduce the number of human infections by L. infantum,” explains ISGlobal researcher and study coordinator Albert Picado, who explains that treated baits or chewable tablets could facilitate their administration. “In addition, the model results will help us define the insecticide product profile and how to apply it to maximise its effectiveness,” he adds. This will guide the development of new products or the repurposing of existing ones for their use as a public health intervention to control zoonotic visceral leishmaniasis in endemic regions.